awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q39012896-6C43526A-777F-4D3F-8B92-1AF81A433B3F
Q39012896-6C43526A-777F-4D3F-8B92-1AF81A433B3F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39012896-6C43526A-777F-4D3F-8B92-1AF81A433B3F
Mechanisms of action that contribute to efficacy of omalizumab in chronic spontaneous urticaria.
P2860
Q39012896-6C43526A-777F-4D3F-8B92-1AF81A433B3F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39012896-6C43526A-777F-4D3F-8B92-1AF81A433B3F
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
fd2c687506174ab8e3e4876b9d72bbe6622302fb
P2860
Pharmacokinetics, pharmacodynamics and safety of QGE031 (ligelizumab), a novel high-affinity anti-IgE antibody, in atopic subjects.